In this issue
NHS Grampian project: treating uncomplicated lower urinary tract infection in community pharmacySubscription
Urinary tract infections (UTIs) are one of the most common conditions seen in female patients in general practice (GP) and account for 1–3% of all GP consultations each year in the UK. Over-the-counter (OTC) treatments for UTIs currently available in community pharmacy only attempt to relieve symptoms, and do not address the bacterial infection. The Grampian project was developed to provide treatment of uncomplicated UTIs through community pharmacies by means of a Patient Group Direction ...
When the UK was engaged in military operation in Iraq and Afghanistan in 2007, the UK press reported a fivefold increase in the cocaine-positive rate of British soldiers, which was followed by a switch from cocaine to mephedrone. What can we learn from this, in the light of a current reported high rate of positive compulsory drug test results in the British Army?
New research into blood pressure measurements taken in different settings could help pharmacists interpret blood pressure readings better and help them offer appropriate advice to patients.
Stroke: classification and diagnosisSubscription
In light of the many pressures currently facing the NHS, as well as an ever increasing ageing population, pharmacists and healthcare professionals should be aware of the risk factors for stroke, its classification and diagnosis.
Preliminary results of a specialist pharmacist-led polypharmacy clinic for patients with prostate cancerSubscription
Polypharmacy — the use of multiple medications by a patient — generally occurs in older adults aged 65 years and over. The increasing number of treatment options and an ageing population mean that, anecdotally, we are seeing more patients with co-morbidities. The multiple specialisms involved in various aspects of cancer patient care can lead to no one taking responsibility for the patient as a whole, which may result in poorer therapeutic outcomes and inappropriate polypharmacy
This letter is in response to ‘Health literacy, medication adherence and thriving healthcare systems: connecting the dots’.
There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only ...
Impact of measures introduced to control meropenem consumption in a district general hospital over a 2-year periodSubscription
Meropenem is a broad-spectrum antipseudomonal carbapenem antibiotic. Controlling the prescribing of carbapenems is important in our efforts to curb the development of carbapenem-resistant Gram-negative organisms, which already pose a serious health threat to many parts of the UK.
Claims of cancer drugs’ survival benefits must be accurate. To avoid fashion and fads, we must carefully examine the clinical and economic implications of newly approved cancer drugs before we seat them on the ‘breakthrough’ throne.